Socioeconomic Status, Sex, Age and Access to Medications for COPD in Ontario, Canada

Abstract Disparities in COPD health outcomes have been found with older individuals, men and those of lower socioeconomic status doing worse. We sought to determine if this was due to differences in access to COPD medications. We conducted a retrospective cohort study using population health administrative data from Ontario, Canada, a province with universal prescription drug coverage for older adults. All individuals with COPD aged 67 years and older in 2008 who were not taking inhaled long-acting bronchodilators or inhaled corticosteroids were followed for 2 years. Poisson regression was used to determine the effects of age, sex, and socioeconomic status on the likelihood of initiating one of these medications, after adjusting for potential confounders. Over the study period, 54,050 of 185,698 (29.1%) older individuals with COPD not previously taking any inhaled long-acting bronchodilators or corticosteroids were initiated on one or more of these medications. After adjustment, individuals of low socioeconomic status, measured using neighborhood income level quintiles, were slightly more likely to initiate COPD medications than those of high socioeconomic status (relative risk (RR) 1.05; 95% confidence interval (95% CI) 1.02–1.08). While men received COPD medication at a consistent rate across all age groups, the likelihood that a woman received medication decreased with increasing age. With the exception of older women, there was minimal disparity in prescription for COPD medications. Disparity in health outcomes among Ontario COPD patients is not clearly explained by differences in medication access by socioeconomic status, sex or age.

[1]  T. To,et al.  Trends in socioeconomic status-related differences in mortality among people with chronic obstructive pulmonary disease. , 2014, Annals of the American Thoracic Society.

[2]  D. Feig,et al.  Near equality in quality for medication utilization among older adults with diabetes with universal medication insurance in Ontario, Canada. , 2014, Journal of evaluation in clinical practice.

[3]  L. Rabeneck,et al.  Disparities in Receipt of Screening Tests for Cancer, Diabetes and High Cholesterol in Ontario, Canada: A Population-based Study Using Area-based Methods , 2013, Canadian Journal of Public Health.

[4]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[5]  B. Jackson,et al.  Chronic Obstructive Pulmonary Disease and SocioEconomic Status: a Systematic Review , 2012, COPD.

[6]  R. Moineddin,et al.  Development of the Canadian Marginalization Index: a new tool for the study of inequality. , 2012, Canadian journal of public health = Revue canadienne de sante publique.

[7]  S. Rozenfeld,et al.  Inappropriate medication use among the elderly: a systematic review of administrative databases , 2011, BMC geriatrics.

[8]  Lonny Reisman,et al.  Full coverage for preventive medications after myocardial infarction. , 2011, The New England journal of medicine.

[9]  T. To,et al.  Comparison of Inhaled Long-Acting β-Agonist and Anticholinergic Effectiveness in Older Patients With Chronic Obstructive Pulmonary Disease , 2011, Annals of Internal Medicine.

[10]  S. Gregorich,et al.  Socioeconomic gradients in tiotropium use among adults with COPD , 2008, International journal of chronic obstructive pulmonary disease.

[11]  Meilan K. Han,et al.  Gender and chronic obstructive pulmonary disease: why it matters. , 2007, American journal of respiratory and critical care medicine.

[12]  Ross Upshur,et al.  Mortality of elderly patients in Ontario after hospital admission for chronic obstructive pulmonary disease. , 2007, Canadian respiratory journal.

[13]  D. Mannino,et al.  International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study , 2007, The Lancet.

[14]  D. Berlowitz,et al.  Sex differences in inappropriate prescribing among elderly veterans. , 2007, The American journal of geriatric pharmacotherapy.

[15]  Bartolome Celli,et al.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. , 2007, The New England journal of medicine.

[16]  J. Bourbeau,et al.  Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis , 2006, Thorax.

[17]  P. Austin,et al.  Socioeconomic status, service patterns, and perceptions of care among survivors of acute myocardial infarction in Canada. , 2004, JAMA.

[18]  M. Finkelstein Ecologic proxies for household income: how well do they work for the analysis of health and health care utilization? , 2004, Canadian journal of public health.

[19]  S. Hurd,et al.  Global Strategy for the Diagnosis, Management and Prevention of COPD: 2003 update , 2003, European Respiratory Journal.

[20]  Xiaonan Xue,et al.  Estimating the relative risk in cohort studies and clinical trials of common outcomes. , 2003, American journal of epidemiology.

[21]  J. Tu,et al.  Effect of Socioeconomic Status on Treatment and Mortality After Stroke , 2002, Stroke.

[22]  D. Tashkin,et al.  Gender bias in the diagnosis of COPD. , 2001, Chest.

[23]  N. Roos,et al.  Performance of the ACG Case-Mix System in Two Canadian Provinces , 2001, Medical care.

[24]  P. Austin,et al.  Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. , 1999, The New England journal of medicine.

[25]  J. Vestbo,et al.  Socioeconomic status and chronic obstructive pulmonary disease , 1999, Thorax.

[26]  N. Krieger Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. , 1992, American journal of public health.

[27]  Ross E. G. Upshur,et al.  Comparison of Inhaled Long-Acting (cid:1) -Agonist and Anticholinergic Effectiveness in Older Patients With Chronic Obstructive Pulmonary Disease A Cohort Study , 2011 .

[28]  Sean Keenan,et al.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. , 2007, Canadian respiratory journal.

[29]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .